CH552389A - Verfahren zur herstellung eines oral zu verabreichenden kohlenwasserstoffgemisches. - Google Patents
Verfahren zur herstellung eines oral zu verabreichenden kohlenwasserstoffgemisches.Info
- Publication number
- CH552389A CH552389A CH457266A CH457266A CH552389A CH 552389 A CH552389 A CH 552389A CH 457266 A CH457266 A CH 457266A CH 457266 A CH457266 A CH 457266A CH 552389 A CH552389 A CH 552389A
- Authority
- CH
- Switzerland
- Prior art keywords
- petroleum fraction
- hydrocarbon mixture
- refined
- boiling
- administered
- Prior art date
Links
- 229930195733 hydrocarbon Natural products 0.000 title claims abstract description 23
- 150000002430 hydrocarbons Chemical class 0.000 title claims abstract description 23
- 239000003208 petroleum Substances 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title abstract 3
- 238000009835 boiling Methods 0.000 claims abstract description 16
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 15
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 9
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 7
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 201000009030 Carcinoma Diseases 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 230000009286 beneficial effect Effects 0.000 claims description 4
- 201000011510 cancer Diseases 0.000 claims description 4
- 238000004508 fractional distillation Methods 0.000 claims description 4
- 230000035876 healing Effects 0.000 claims description 4
- 230000001590 oxidative effect Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 2
- 206010027476 Metastases Diseases 0.000 claims description 2
- 206010028813 Nausea Diseases 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 claims description 2
- 206010047700 Vomiting Diseases 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 230000000711 cancerogenic effect Effects 0.000 claims description 2
- 231100000315 carcinogenic Toxicity 0.000 claims description 2
- 238000004042 decolorization Methods 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 230000002542 deteriorative effect Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 208000030159 metabolic disease Diseases 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims description 2
- 230000009401 metastasis Effects 0.000 claims description 2
- 210000003470 mitochondria Anatomy 0.000 claims description 2
- 230000008693 nausea Effects 0.000 claims description 2
- 239000002574 poison Substances 0.000 claims description 2
- 231100000614 poison Toxicity 0.000 claims description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims description 2
- 231100000331 toxic Toxicity 0.000 claims description 2
- 230000002588 toxic effect Effects 0.000 claims description 2
- 230000008673 vomiting Effects 0.000 claims description 2
- VEXDRERIMPLZLU-UHFFFAOYSA-N 3-hydroxy-2-methylbutanoic acid Chemical compound CC(O)C(C)C(O)=O VEXDRERIMPLZLU-UHFFFAOYSA-N 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract 1
- YDSWCNNOKPMOTP-UHFFFAOYSA-N mellitic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(O)=O)=C(C(O)=O)C(C(O)=O)=C1C(O)=O YDSWCNNOKPMOTP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000003209 petroleum derivative Substances 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G53/00—Treatment of hydrocarbon oils, in the absence of hydrogen, by two or more refining processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
- C10G67/00—Treatment of hydrocarbon oils by at least one hydrotreatment process and at least one process for refining in the absence of hydrogen only
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT322665 | 1965-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH552389A true CH552389A (de) | 1974-08-15 |
Family
ID=3547321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH457266A CH552389A (de) | 1965-04-08 | 1966-03-30 | Verfahren zur herstellung eines oral zu verabreichenden kohlenwasserstoffgemisches. |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH552389A (enrdf_load_stackoverflow) |
DE (1) | DE1545304A1 (enrdf_load_stackoverflow) |
FR (1) | FR5795M (enrdf_load_stackoverflow) |
GB (1) | GB1122679A (enrdf_load_stackoverflow) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3484766D1 (de) | 1983-11-17 | 1991-08-08 | Helmut Dr Med Opel | Oberflaechenanalgetikum und -antiphlogistikum. |
-
1966
- 1966-03-28 DE DE19661545304 patent/DE1545304A1/de active Pending
- 1966-03-30 GB GB13984/66A patent/GB1122679A/en not_active Expired
- 1966-03-30 CH CH457266A patent/CH552389A/de not_active IP Right Cessation
- 1966-07-07 FR FR68559A patent/FR5795M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1545304A1 (de) | 1969-07-10 |
FR5795M (enrdf_load_stackoverflow) | 1968-02-12 |
GB1122679A (en) | 1968-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3940091C2 (enrdf_load_stackoverflow) | ||
DE2240782A1 (de) | Verfahren zur herstellung eines eisensaccharid-komplexes | |
DE1767098C2 (de) | Verfahren zur Gewinnung eines vasoaktiven Arzneimittels aus den Blättern von Ginkgo biloba | |
DE1792565A1 (de) | Arzneimittel | |
AT390610B (de) | Verfahren zur herstellung von neuen platin-(ii) -diaminkomplexen | |
DE2060601A1 (de) | Nahrungsergaenzungsmittel | |
CH552389A (de) | Verfahren zur herstellung eines oral zu verabreichenden kohlenwasserstoffgemisches. | |
DE2407398B2 (de) | Verfahren zur herstellung einer mischung aus brenzkatechin und hydrochinon | |
AT85031B (de) | Verfahren zur Darstellung von basisch gerbsaurem Aluminium. | |
AT135119B (de) | Verfahren zur geruchlichen und geschmacklichen Verbesserung von vitaminhaltigen Fischölen. | |
DE2159322C2 (de) | Pharmazeutische Zubereitung für die Lithium-Therapie | |
EP0305902B1 (de) | Arzneimittel | |
DE876570C (de) | Verfahren zur Herstellung therapeutisch wertvoller Kolloidloesungen | |
AT103899B (de) | Verfahren zur Trennung von Zirkonium- und Hafniumverbindungen. | |
AT368132B (de) | Verfahren zur herstellung von neuen produkten bestehend aus fuer die therapeutische anwendung genuegend reinen isobuttersaeureaniliden | |
EP0173240B1 (de) | Injektionslösung | |
DE2100691C (de) | Papaverinmonopyndoxalphosphat und Verfahren zu seiner Herstellung | |
DE504683C (de) | Verfahren zur Darstellung von ª‰-[3,5-Dijod-4-(3,5-dibrom- bzw. dichlor-4-oxyphenoxy)-phenyl]-ª‡-aminopropionsaeure | |
DE1271097B (de) | Verfahren zur Reduktion von Ferri-Ionen zu Ferro-Ionen in einer waessrigen, Ferri- und Fluorid-Ionen enthaltenden Aluminiumsalzloesung | |
DE486492C (de) | Reindarstellung von AEthylenchlorhydrin | |
DE963512C (de) | Verfahren zur Herstellung von kristallisierbaren 2, 6-trans, trans-Pentaenaldehydkomplexverbindungen mit Vitamin A-aldehydaufbau | |
AT203639B (de) | Verfahren zur Herstellung von elementarem Silber mit hohen bakteriziden Eigenschaften und katalytischer Aktivität | |
DE615133C (de) | Verfahren zur Trennung von 3- und 5-Chlor-2-oxydiphenyl | |
DE3402259A1 (de) | Therapeutisch wirksames gemisch, insbesondere zur behandlung von infektionskrankheiten im hals-, nasen- ohrenbereich, stimmbandentzuendungen, schwerer heiserkeit und trombophlebitis | |
AT333727B (de) | Verfahren zur herstellung des neuen 4- (p-chlorphenoxyacetylamino) -benzoesaurediathylaminoathylester -p- chlorphenoxyisobutyrats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |